Stay updated on Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays the updated revision label v3.7.0, replacing the older v3.6.6. This appears to be a metadata update that does not alter study data or eligibility details.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision label on the page was updated from v3.6.5 to v3.6.6, indicating an administrative update to the trial details entry.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating an administrative update to the ClinicalTrials.gov page. This change does not modify study content, eligibility criteria, or user-facing information.SummaryDifference0.0%

- Check51 days agoChange DetectedThe study record version was updated from v3.6.3 to v3.6.4, indicating a small documentation update. It does not reflect changes to eligibility, endpoints, or treatment.SummaryDifference0.0%

- Check65 days agoChange DetectedPublications section added with a citation to the Pembrolizumab, Temozolomide and HSPPC-96 vaccine study in newly diagnosed GBM, and a note that entries are auto-filled from PubMed.SummaryDifference0.2%

- Check72 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, signaling a new release of the page’s content rather than a change to its substantive information.SummaryDifference0.0%

Stay in the know with updates to Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page.